中国麻风皮肤病杂志 ›› 2023, Vol. 39 ›› Issue (10): 716-718.doi: 10.12144/zgmfskin202310716

• 论著 • 上一篇    下一篇

儿童接种新冠疫苗后玫瑰糠疹临床特征分析

郑冰洁,林晓,王艺蓉,贾华琴,姚晨龙,钱秋芳   

  1. 上海市儿童医院，上海交通大学医学院附属儿童医院皮肤科，上海，200062
  • 出版日期:2023-10-15 发布日期:2023-10-11

Clinical characteristics of children with pityriasis rosea after COVID-19 vaccine

ZHENG Bingjie, LIN Xiao, WANG Yirong, JIA Huaqin, YAO Chenlong, QIAN Qiufang   

  1. Department of Dermatology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
  • Online:2023-10-15 Published:2023-10-11

PDF (PC)

64

摘要： 目的：了解儿童接种新冠疫苗后罹患玫瑰糠疹的临床特征。方法：检索我院2020年8月至2022年3月接种新冠疫苗后诊断为玫瑰糠疹的病例。采集详细病史、体格检查、血常规、嗜酸性粒细胞计数等数据并进行回顾性分析。结果：21例患儿被纳入分析，其中男9例，女12例，平均年龄为(9.48±2.14)岁。19例提供了疫苗详情的患儿中，63.2%（12/19）接种第1剂后出现皮疹，31.6%（6/19）接种第2剂后出现皮疹。接种疫苗后出现皮疹的时间平均为(6±3.67)天，皮疹持续时间平均(41.6±23.97)天。结论：玫瑰糠疹为接种新冠疫苗后出现的轻型、自限性皮肤不良事件。

关键词: 玫瑰糠疹, 新型冠状病毒, 疫苗, 儿童

Abstract:

Objective: To investigate the clinical characteristics of pityriasis rosea in children after COVID-19 vaccination. Methods: The data of cases with pityriasis rosea from August 2020 to March 2022 who were diagnosed with pityriasis rosea after vaccination were analyzed, including detailed history, physical examination, blood count, eosinophil count, etc.. Results: Twenty-one children were included in the analysis, including 9 males and 12 females, with a mean age of 9.48±2.14 years. Of the 19 children who provided vaccine details, 63.2% (12/19) developed a rash after receiving the first dose and 31.6% (6/19) developed a rash after receiving the second dose. The average time to rash after vaccination is 6±3.67 days, and the average duration of rash was 41.6±23.97 days. Conclusion: Pityriasis rosea is a mild, self-limiting skin adverse event that occurs after vaccination against COVID-19.

Key words: pityriasis rosea, COVID-19, vaccine, children